NOF Corporation (TYO:4403)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Unallocated Adjustment	-13.82B	-12.95B	-17.41B	-16.93B	-13.18B
Explosives & Propulsion	38.79B	34.15B	29.89B	30.03B	30.09B
Explosives & Propulsion Growth	13.57%	14.27%	-0.46%	-0.20%	-5.55%
Functional Chemicals	154.69B	137.37B	147.75B	129.73B	110.65B
Functional Chemicals Growth	12.61%	-7.03%	13.89%	17.24%	-6.44%
Others	9.50B	8.68B	8.65B	8.78B	9.40B
Others Growth	9.46%	0.40%	-1.47%	-6.66%	-2.74%
Pharmaceuticals, Medicals and Health	49.14B	54.99B	48.83B	41.04B	35.68B
Pharmaceuticals, Medicals and Health Growth	-10.64%	12.63%	18.98%	15.02%	6.86%
Total	238.31B	222.25B	217.71B	192.64B	172.64B
Total Growth	7.22%	2.09%	13.01%	11.58%	-4.57%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Japan	165.91B	147.85B	144.38B	129.52B	122.47B
Japan Growth	12.22%	2.40%	11.47%	5.76%	-5.15%
Asia	37.52B	35.83B	38.13B	33.40B	29.43B
Asia Growth	4.73%	-6.04%	14.15%	13.51%	-4.07%
Europe	20.48B	22.20B	-	-	-
Europe Growth	-7.74%	-	-	-	-
Others	14.39B	16.37B	35.20B	29.72B	20.75B
Others Growth	-12.09%	-53.48%	18.45%	43.22%	-1.78%
Total	238.31B	222.25B	217.71B	192.64B	172.64B
Total Growth	7.22%	2.09%	13.01%	11.58%	-4.57%

Source: S&P Global Market Intelligence.